Sorbonne Université, INSERM, UMR_S 1155, AP-HP, Hôpital Tenon, Paris, France.
Service d'Oto-rhino-laryngologie et de Chirurgie Cervico-Faciale, Hôpital Tenon, Paris, France.
PLoS One. 2019 Oct 24;14(10):e0224138. doi: 10.1371/journal.pone.0224138. eCollection 2019.
Thyroid calcification is frequent in thyroid nodules. The aim of our study was to evaluate the prevalence of calcifications in thyroid tissue samples of patients with various thyroid diseases, and to identify their composition according to their localization. Among 50 thyroid samples included, 56% were malignant (papillary carcinoma) and 44% were benign (adenoma, multinodular goiter, Graves' disease, sarcoidosis). Calcifications were found in 95% of samples using polarised light microscopy, whereas only 12% were described in initial pathological reports. Three types were individualised and analyzed by infrared spectrometry (μFTIR): colloid calcifications composed of calcium oxalate, capsular calcifications and psammoma bodies, both composed of calcium phosphate. Of notice, psammoma bodies characterized by FE-SEM were composed of concentric structure suggesting a slow process for crystal deposition. Calcium phosphates were found only in malignant samples whereas calcium oxalate was not associated with a define pathology. Proliferation assessed by KI67 staining was high (33% of positive follicles), and RUNX2, OPN, and CD44 positive staining were detected in thyrocytes with a broad variation between samples. However, thyrocyte proliferation and differentiation markers were not associated with the number of crystals. TRPV5 and CaSR expression was also detected in thyrocytes. mRNA transcripts expression was confirmed in a subgroup of 10 patients, altogether with other calcium transporters such as PMCA1 or Cav1.3. Interestingly, TRPV5 mRNA expression was significantly associated with number of colloid calcifications (rho = -0.72; p = 0.02). The high prevalence of calcium oxalate crystals within colloid gel raises intriguing issues upon follicle physiology for calcium and oxalate transport.
甲状腺钙化在甲状腺结节中很常见。我们的研究目的是评估不同甲状腺疾病患者甲状腺组织样本中钙化的发生率,并根据其位置确定其成分。在纳入的 50 个甲状腺样本中,56%为恶性(乳头状癌),44%为良性(腺瘤、多结节性甲状腺肿、格雷夫斯病、结节病)。使用偏光显微镜发现 95%的样本有钙化,而初始病理报告仅描述了 12%的样本有钙化。通过红外光谱(μFTIR)对 3 种类型进行了个体化分析:由草酸钙组成的胶体钙化、包膜钙化和砂粒体,两者均由磷酸钙组成。值得注意的是,FE-SEM 特征化的砂粒体由同心结构组成,提示晶体沉积过程缓慢。磷酸钙仅在恶性样本中发现,而草酸钙与明确的病理无关。通过 KI67 染色评估的增殖率很高(33%的阳性滤泡),在甲状腺细胞中检测到 RUNX2、OPN 和 CD44 的阳性染色,样本间存在广泛的差异。然而,甲状腺细胞的增殖和分化标志物与晶体数量无关。TRPV5 和 CaSR 在甲状腺细胞中也有表达。在 10 名患者的亚组中,与其他钙转运体(如 PMCA1 或 Cav1.3)一起证实了 mRNA 转录物的表达。有趣的是,TRPV5 mRNA 表达与胶体钙化的数量呈显著负相关(rho=-0.72;p=0.02)。胶体凝胶中草酸钙晶体的高发生率提出了关于钙和草酸钙运输的滤泡生理学的有趣问题。